SecBot SecBot

GKOS

GLAUKOS Corp
NYSE· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001192448 Healthcare & Medical Devices
$244.88 −0.84 (−0.34%)
Nov 16 4:00 PM ET · prev $245.72
Market cap
$14.6B
Large cap
Consensus
Buy
90% Buy or better · 20 analysts
Median target
🔒 Subscribers only
1 year
+177.0%
from $88.40 · Nov 17
30 days
+46.7%
from $166.96
52-week range
$88.40–247.16
−1% from high · low Nov 17
Avg volume 20D
1.90M
Nov 3 spike 10.74M
Short interest
4.48M
≈7.6% of shares · +3.2%
Days to cover
2.9
at average volume
Insider net
−$32.6M
since Jul 6 · excl. 6 subscriber-only trades
New fund stakes
2
Q3 2026 13F · 3 exits
Filing reports
16
analyzed by SecBot
SecBot read MIXED 8 reports · 90 days
Balance 0 bearish · 1 bullish · 7 neutral oldest → newest, height = score
Avg score ·High conf. 5/8

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

  • Jul 6 HC Wainwright & Co. initiates
  • Jul 9 to Jul 16 ▼ 2 days of insider sells: $3.1M by 1 insider, avg $157.50
  • Jul 31 to Aug 11 ▼ 3 days of insider sells: $14.5M by 3 insiders, avg $179.76
  • Aug 19 ▼ 1 insider sell $475.0K at $190.00
  • Aug 28 ▼ 1 insider sell $2.5M at $180.67
  • Sep 16 ▼ 1 insider sell $243.2K at $166.92
  • Sep 25 ▼ 1 insider sell $249.2K at $154.28
  • Oct 5 ▼ 1 insider sell $251.1K at $164.45
  • Oct 28 ▲ Glaukos reported Q3 2026 record net sales of $211.0M (+58% YoY), wel…
  • Oct 28 ▲ Earnings: GKOS Q3 2026 Earnings: EPS $0.47 (+612.0% vs est)
  • Oct 30 to Nov 4 ▼ 2 days of insider sells: $11.3M by 2 insiders, avg $239.72
  • Nov 12 New insider trade: subscribers see the details Unlock

Signal stack

Where each data set points today.

  • InsidersMIXED

    5 insiders sold $32.6M. Excludes 6 subscriber-only trades.

  • InstitutionsBULLISH

    Q3 2026: 39 added (2 new), 24 trimmed or exited. Largest new: M&G $14.0M.

  • AnalystsBULLISH

    18 of 20 rate it Buy or better.

  • Short sellersSTEADY

    Short interest +3.2% to 4.48M shares. 2.9 days to cover, ≈7.6% of shares.

  • TrendUPTREND

    32% above its 50-day average. New closing high $247.16 on Nov 11.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 31.

Who's buying

13F· Q3 2026
2
new positions
3
exits
$14.0M
in new stakes · top 1 shown
FundMoveSharesValue
FMR LLCDOUBLED2,867,943$470.9M
Invesco Ltd.ADD1,235,308$202.8M
WESTFIELD CAPITAL MANAGEMENT CO LPADD786,139$129.1M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED652,611$107.2M
Artisan Partners Limited PartnershipADD599,548$98.4M
PUBLIC SECTOR PENSION INVESTMENT BOARDADD303,984$50.9M
UBS Group AGTRIM306,215$50.3M
RENAISSANCE TECHNOLOGIES LLCADD268,692$44.1M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

20 analysts
Buy 90% rate it Buy or better
Strong Buy8Buy10Hold2Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Nov 16, 2026🔒 Fresh data, subscribers only
MAINTAIN
MAINTAIN
Oct 29, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Oct 29, 2026JP Morgan
MAINTAIN
MAINTAINOverweight
Oct 29, 2026Citigroup
MAINTAIN
MAINTAINBuy
Oct 29, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Oct 29, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight

Insider ledger

Form 4
$0
bought · 0 insiders
$32.6M
sold · 5 insiders · excl. 6 subscriber-only trades
DateInsiderTypeValue
Nov 12, 2026🔒 Fresh data, subscribers only
Nov 12, 2026
SELL
Nov 12, 2026🔒 Fresh data, subscribers only
Nov 12, 2026
SELL
Nov 12, 2026🔒 Fresh data, subscribers only
Nov 12, 2026
SELL
Nov 12, 2026🔒 Fresh data, subscribers only
Nov 12, 2026
SELL
Nov 12, 2026🔒 Fresh data, subscribers only
Nov 12, 2026
SELL
Nov 12, 2026🔒 Fresh data, subscribers only
Nov 12, 2026
EXERCISE
Nov 12, 2026🔒 Fresh data, subscribers only
Nov 12, 2026
SELL
Nov 12, 2026🔒 Fresh data, subscribers only
Nov 12, 2026
EXERCISE

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

28 lobbying filings and 5 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
4,483,891
shares short
+3.2%
vs prior settlement
2.9
days to cover
≈7.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 12, 2026 SEC
Joseph E. Gilliam, an officer of Glaukos Corp, filed a Form 144 notice of intent to sell 44,917 shares of common…
144 · Impact 3/10
Nov 12, 2026 Insider
🔒 Fresh data, subscribers only
Nov 12, 2026 Insider
🔒 Fresh data, subscribers only
Nov 12, 2026 Insider
🔒 Fresh data, subscribers only
Nov 6, 2026 SEC
Glaukos filed an 8-K to post a November 2026 investor presentation. The presentation reiterates the company's pipeline…
8-K · Impact 3/10
Oct 28, 2026 Earnings result
GKOS Q3 2026 Earnings: EPS $0.47 (+612.0% vs est)
Sep 30, 2026 Inst.
FMR LLC · DOUBLED
2,867,943 shares ($470.9M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
3 drugs tracked · Drug pipeline →
Recent

SecBot reports

16 filings · 1 bullish · 0 bearish · 15 neutral
All GKOS filing & press-release reports (16)